Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon
- PMID: 1941625
Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon
Abstract
The 5-hydroxytryptamine (serotonin; 5-HT) agonists, RU-24969 [5-methoxy 3-(1,2,3,6-tetrahydro-4-pyridinyl)1H-indole, succinate], ipsapirone [2-(4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl)-1,2- benzisothiazol-3-(2H)one-1,1-dioxidehydrochloride], 8-hydroxy-N,N-dipropyl-2-aminotetralin, lysergic acid diethylamide, fenfluramine and N,N-dimethyltryptamine were studied in pigeons trained to discriminate quipazine (1.0 mg/kg) from saline and in pigeons trained to discriminate I-5-HTP (18.0 mg/kg) from saline. Lysergic acid diethylamide, quipazine and fenfluramine generalized to the training stimulus in both groups of pigeons. N,N-dimethyltryptamine generalized to quipazine in all pigeons tested whereas N,N-dimethyltryptamine generalized to I-5-HTP in most pigeons tested. The natural substrate 5-HT and agonists with affinities for the 5-HT1 receptor and its subtypes (8-hydroxy-N,N-dipropyl-2-aminotetralin, ipsapirone, and RU-24969) only generalized in the I-5-HTP-trained pigeons. Equilibrium binding experiments using the ligands [3H]-5-HT and [3H]ketanserin were performed with six areas of pigeon brain and six homologous areas of rat brain. Two populations of 5-HT binding sites were found in brains of both species; one defined by high-affinity binding of [3H]-5-HT and the other defined by high-affinity binding of [3H]ketanserin. Kd values were similar for the two ligands in brains of both species. 5-HT, RU-24969 and ipsapirone displaced [3H]-5-HT but not [3H]ketanserin from pigeon brain membranes. The present study suggests that, in the pigeon, the 5-HT2 receptor might mediate the discriminative-stimulus effects of quipazine, whereas the 5-HT1 receptor might mediate the effects of I-5-HTP.
Similar articles
-
Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.J Pharmacol Exp Ther. 1991 Sep;258(3):999-1007. J Pharmacol Exp Ther. 1991. PMID: 1890629
-
Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.J Neurochem. 1986 Aug;47(2):529-40. doi: 10.1111/j.1471-4159.1986.tb04532.x. J Neurochem. 1986. PMID: 2942638
-
Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine.Psychopharmacology (Berl). 1987;93(2):158-66. doi: 10.1007/BF00179927. Psychopharmacology (Berl). 1987. PMID: 3122248
-
Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.J Pharmacol Exp Ther. 1984 Mar;228(3):628-35. J Pharmacol Exp Ther. 1984. PMID: 6707913
-
Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.Pharmacol Biochem Behav. 2002 May;72(1-2):77-85. doi: 10.1016/s0091-3057(01)00723-7. Pharmacol Biochem Behav. 2002. PMID: 11900772
Cited by
-
Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.Psychopharmacology (Berl). 2010 Aug;211(2):149-59. doi: 10.1007/s00213-010-1893-9. Epub 2010 Jun 5. Psychopharmacology (Berl). 2010. PMID: 20526585
-
Complex stimulus properties of LSD: a drug discrimination study with alpha 2-adrenoceptor agonists and antagonists.Psychopharmacology (Berl). 1995 Aug;120(4):384-91. doi: 10.1007/BF02245809. Psychopharmacology (Berl). 1995. PMID: 8539318
-
Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.Psychopharmacology (Berl). 2005 Jun;179(4):854-62. doi: 10.1007/s00213-004-2108-z. Epub 2005 Jan 12. Psychopharmacology (Berl). 2005. PMID: 15645221